Diamondback Energy, one of the largest U.S. shale producers, has agreed to acquire Double Eagle's oil-and-gas assets for roughly $5.03 billion in a mix of cash and stock. The purchase adds about 176,000 net acres in the Midland Basin, the most productive core of the Permian region that spans West Texas and New Mexico.
The deal is the latest in a series of acquisitions by Diamondback as it seeks to consolidate its position in the Permian. Earlier this year, the company announced a $26 billion agreement to buy Endeavor Energy Partners, a move that already made it one of the biggest players in the basin. This new transaction builds on that strategy, giving Diamondback more drilling locations and longer-running production potential.
What the deal includes
Under the terms, Diamondback will pay about $2.15 billion in cash and issue roughly 15.56 million shares of its common stock. The total value of $5.03 billion is based on Diamondback's closing share price on the Friday before the announcement, according to Reuters calculations.
In return, Diamondback gains acreage in the Midland Basin that the companies estimate could be producing about 35,000 barrels of oil per day by 2027. The deal is expected to close on December 21, subject to customary approvals.
The Midland Basin is prized for its well-understood geology and existing infrastructure, which means new wells can be brought online quickly and at relatively low cost. For Diamondback, adding this acreage concentrates its footprint in an area where it already operates, potentially creating operational efficiencies.
What it means for the broader shale market
Large shale deals like this one do more than just add barrels to a single company's portfolio. They also provide a benchmark for what buyers are willing to pay for Permian inventory, a key metric for investors and analysts.
Using the $5.03 billion price tag, the deal works out to roughly $28,600 per net acre (about $5.03 billion divided by 176,000 acres) and about $144,000 per barrel per day of the 2027 production estimate (about $5.03 billion divided by 35,000 barrels). These ratios are often used by analysts to estimate the net asset value of other Permian-focused producers and to compare M&A valuations across the sector.
If this purchase is seen as a clean read on Midland Basin value, it could raise expectations for what other Permian packages are worth. Conversely, if the market views the price as too high, it might cap valuations for future deals. Investors will be watching how Diamondback's stock reacts and how analysts adjust their models.
Why this matters for everyday investors
For individual investors, this deal is a reminder that consolidation in the energy sector can have ripple effects. When a major producer like Diamondback expands, it often signals confidence in the long-term economics of the region. That can be a positive sign for the broader energy sector, but it also means the company is taking on more debt and issuing new shares, which can dilute existing shareholders.
Diamondback's move also highlights the ongoing trend of shale companies merging to achieve scale. Larger companies can often drill more efficiently and negotiate better terms with suppliers, which can help them weather periods of low oil prices. However, these deals also carry risks, such as integration challenges or paying too much for assets.
For those who own shares of Diamondback or other energy companies, the key takeaway is that M&A activity can affect stock prices in both directions. While a deal like this can boost long-term growth prospects, it can also lead to short-term volatility as investors digest the financial details.
As always, it's wise to consider how any single deal fits into your broader investment strategy. Energy stocks can be cyclical, and their performance is closely tied to oil prices, which are influenced by global supply and demand, geopolitical events, and decisions by major producers like OPEC.
For more on the energy sector, you can read about Saudi stocks holding steady or gold's recent moves. And for context on other large M&A deals, see J&J's talks to buy Ollin Biosciences.


